Insider · CIK 0001741286
GARDNER JASON
Reports to the SEC for 1 company · CAMBRIDGE, MA
Transactions
26
Companies
1
Filings
18
CIK
0001741286
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2022-11-30 | DNTHDianthus Therapeutics, Inc. /DE/A Award | +$2,820 |
| 2022-08-01 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2022-05-31 | DNTHDianthus Therapeutics, Inc. /DE/A Award | +$2,970 |
| 2022-05-17 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2022-02-15 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2021-09-16 | DNTHDianthus Therapeutics, Inc. /DE/S Sale | −$96.5K |
| 2021-09-14 | DNTHDianthus Therapeutics, Inc. /DE/A Award | — |
| 2021-08-02 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2021-02-11 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2020-02-10 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2020-01-10 | DNTHDianthus Therapeutics, Inc. /DE/S Sale | −$171K |
| 2020-01-02 | DNTHDianthus Therapeutics, Inc. /DE/S Sale | −$42.3K |
| 2019-12-23 | DNTHDianthus Therapeutics, Inc. /DE/S Sale | −$43.8K |
| 2019-12-20 | DNTHDianthus Therapeutics, Inc. /DE/S Sale | −$1.16M |
| 2019-12-10 | DNTHDianthus Therapeutics, Inc. /DE/S Sale | −$66.3K |
| 2019-06-21 | DNTHDianthus Therapeutics, Inc. /DE/S Sale | −$186K |
| 2019-06-20 | DNTHDianthus Therapeutics, Inc. /DE/S Sale | −$25.2K |
| 2019-02-05 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2018-06-25 | DNTHDianthus Therapeutics, Inc. /DE/C Conversion | — |
| 2018-06-25 | DNTHDianthus Therapeutics, Inc. /DE/C Conversion | — |
| 2018-06-25 | DNTHDianthus Therapeutics, Inc. /DE/P Purchase | +$6,000 |
| 2018-06-25 | DNTHDianthus Therapeutics, Inc. /DE/ · Series A Preferred StockC Conversion | — |
| 2018-06-25 | DNTHDianthus Therapeutics, Inc. /DE/ · Series A Preferred StockC Conversion | — |
| 2018-06-25 | DNTHDianthus Therapeutics, Inc. /DE/ · Series B Preferred StockC Conversion | — |
| 2018-06-25 | DNTHDianthus Therapeutics, Inc. /DE/ · Series B Preferred StockC Conversion | — |
| 2018-06-25 | DNTHDianthus Therapeutics, Inc. /DE/ · Series C Preferred StockC Conversion | — |
Recent filings
- 4GARDNER JASON0000899243-22-037431SEC(opens sec.gov)
- 4GARDNER JASON0000899243-22-027271SEC(opens sec.gov)
- 4GARDNER JASON0000899243-22-021184SEC(opens sec.gov)
- 4GARDNER JASON0000899243-22-018817SEC(opens sec.gov)
- 4GARDNER JASON0000899243-22-006830SEC(opens sec.gov)
- 4GARDNER JASON0000899243-21-036599SEC(opens sec.gov)
- 4GARDNER JASON0000899243-21-036335SEC(opens sec.gov)
- 4GARDNER JASON0000899243-21-031272SEC(opens sec.gov)
- 4GARDNER JASON0000899243-21-006710SEC(opens sec.gov)
- 4GARDNER JASON0000899243-20-004301SEC(opens sec.gov)
- 4GARDNER JASON0001562180-20-000327SEC(opens sec.gov)
- 4GARDNER JASON0001562180-20-000118SEC(opens sec.gov)
- 4GARDNER JASON0001562180-19-006252SEC(opens sec.gov)
- 4GARDNER JASON0001562180-19-006221SEC(opens sec.gov)
- 4GARDNER JASON0001562180-19-006078SEC(opens sec.gov)
- 4GARDNER JASON0001562180-19-003623SEC(opens sec.gov)
- 4GARDNER JASON0000899243-19-002869SEC(opens sec.gov)
- 4GARDNER JASON0000899243-18-018316SEC(opens sec.gov)
Companies
Address
C/O MAGENTA THERAPEUTICS, INC. 50 HAMPSHIRE STREET
CAMBRIDGE, MA, 02139